<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jacobson, Anne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Jaff, Michael R.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">State-of-the-Art Revascularization Therapy: Peripheral Artery Disease</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2009-05-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">6-7</style></pages><abstract><style  face="normal" font="default" size="100%">Recently, options for the endovascular treatment of peripheral vascular disease—including carotid artery disease, renal artery disease, and peripheral artery disease of the legs—have expanded dramatically. In general, physicians tend to use endovascular techniques for first-line therapy and reserve surgery for more complex cases. This article discusses the benefits and drawbacks of optimal medical therapy compared with endovascular or surgical approaches to vascular disease.</style></abstract><number><style face="normal" font="default" size="100%">2</style></number><volume><style face="normal" font="default" size="100%">9</style></volume></record></records></xml>